Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 26  Show
  1. 1
    "cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450."
    Domanski T.L., Finta C., Halpert J.R., Zaphiropoulos P.G.
    Mol. Pharmacol. 59:386-392(2001) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, CHARACTERIZATION.
    Category: Expression, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  2. 2
    "Cloning and tissue distribution of a novel human cytochrome P450 of the CYP3A subfamily, CYP3A43."
    Westlind A., Malmebo S., Johansson I., Otter C., Andersson T.B., Ingelman-Sundberg M., Oscarson M.
    Biochem. Biophys. Res. Commun. 281:1349-1355(2001) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY.
    Category: Expression, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  3. 3
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], ALTERNATIVE SPLICING.
    Category: Sequences.
    Tissue: Liver.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 5 other entries.

  4. 4
    "First report of a genetic polymorphism of the cytochrome P450 3A43 (CYP3A43) gene: identification of a loss-of-function variant."
    Cauffiez C., Lo-Guidice J.-M., Chevalier D., Allorge D., Hamdan R., Lhermitte M., Lafitte J.-J., Colombel J.-F., Libersa C., Broly F.
    Hum. Mutat. 23:101-101(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ALLELE CYP3A43*2), VARIANT CYP3A43*3 ALA-340.
    Category: Pathology & Biotech, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 2 other entries.

  5. 5
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 3363 other entries.

  6. 6
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  7. 7
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7).
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50448 other entries.

  8. 8
    "Intergenic mRNA molecules resulting from trans-splicing."
    Finta C., Zaphiropoulos P.G.
    J. Biol. Chem. 277:5882-5890(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: TRANS-SPLICING.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 9 other entries.

  9. 9
    Cited for: SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 95 other entries.

  10. 10
    "Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes."
    Kim K.A., Chung J., Jung D.H., Park J.Y.
    Eur. J. Clin. Pharmacol. 60:575-581(2004) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: Pathway.
    Source: Reactome:R-HSA-2980797.

    This publication is mapped to 3 other entries.

  11. 11
    "Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa."
    Wojnowski L., Turner P.C., Pedersen B., Hustert E., Brockmoller J., Mendy M., Whittle H.C., Kirk G., Wild C.P.
    Pharmacogenetics 14:691-700(2004) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: Pathway.
    Source: Reactome:R-HSA-2980797.

    This publication is mapped to 19 other entries.

  12. 12
    "CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer."
    Zeigler-Johnson C., Friebel T., Walker A.H., Wang Y., Spangler E., Panossian S., Patacsil M., Aplenc R., Wein A.J., Malkowicz S.B., Rebbeck T.R.
    Cancer Res. 64:8461-8467(2004) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Pathology & Biotech, Sequences.
    Annotation: Pathway. [Reactome:R-HSA-2980797]. Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator). [GeneRIF:64816]. Associated with CANCER: prostate cancer. [GAD:121178].
    Source: Reactome:R-HSA-2980797, GeneRIF:64816, GAD:121178.

    This publication is mapped to 8 other entries.

  13. 13
    Category: Pathology & Biotech, Sequences.
    Annotation: Associated with CANCER: prostate cancer. [GAD:121177]. Finds CYP3A43-Pro(340)Ala polymorphism prevalence differs by race and contributes to prostate cancer risk in African Americans; Observational study of gene-disease association. (HuGE Navigator). [GeneRIF:64816].
    Source: GeneRIF:64816, GAD:121177.

    This publication is mapped to 3 other entries.

  14. 14
    "Analysis of restriction fragment length polymorphism of cytochrome P450 3A43 gene and evaluation of the incidence of CYP3A43*1B allele in europeoid residents of West Siberia."
    Shchepotina E.G., Nikishina M.V., Vavilin V.A., Lyakhovich V.V.
    Bull. Exp. Biol. Med. 140:726-728(2005) [PubMed] [Europe PMC] [Abstract]
    Category: Sequences.
    Annotation: analysis of the restriction fragment length polymorphism CYP3A43 gene c1047 > T in europeoid residents of West Siberia; Observational study of genotype prevalence. (HuGE Navigator).
    Source: GeneRIF:64816.

    This publication is mapped to 3 other entries.

  15. 15
    Category: Function.
    Annotation: Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator).
    Source: GeneRIF:64816.

    This publication is mapped to 29 other entries.

  16. 16
    "Association study between single-nucleotide polymorphisms in 199 drug-related genes and commonly measured quantitative traits of 752 healthy Japanese subjects."
    Saito A., Kawamoto M., Kamatani N.
    J. Hum. Genet. 54:317-323(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech, Sequences.
    Annotation: Observational study of gene-disease association. (HuGE Navigator).
    Source: GeneRIF:64816.

    This publication is mapped to 954 other entries.

  17. 17
    "A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers."
    Young R.P., Hopkins R.J., Hay B.A., Epton M.J., Mills G.D., Black P.N., Gardner H.D., Sullivan R., Gamble G.D.
    Postgrad Med J 85:515-524(2009) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Pathology & Biotech.
    Annotation: Not Associated with CANCER: lung cancer. [GAD:566212]. Observational study of gene-disease association gene-gene interaction and gene-environment interaction. (HuGE Navigator). [GeneRIF:64816].
    Source: GeneRIF:64816, GAD:566212.

    This publication is mapped to 1507 other entries.

  18. 18
    "Evaluation of candidate genes for cholinesterase activity in farmworkers exposed to organophosphorus pesticides: association of single nucleotide polymorphisms in BCHE."
    Howard T.D., Hsu F.C., Grzywacz J.G., Chen H., Quandt S.A., Vallejos Q.M., Whalley L.E., Cui W., Padilla S., Arcury T.A.
    Environ. Health Perspect. 118:1395-1399(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Sequences.
    Annotation: Observational study of gene-disease association. (HuGE Navigator).
    Source: GeneRIF:64816.

    This publication is mapped to 160 other entries.

  19. 19
    Category: Pathology & Biotech, Sequences.
    Annotation: No differences in genotype frequencies between cases and controls were observed indicating that CYP3A43_74_delA is not associated with breast cancer risk.
    Source: GeneRIF:64816.

    This publication is mapped to 3 other entries.

  20. 20
    "Genetic variations in androgen metabolism genes and associations with prostate cancer in South African men."
    Fernandez P., De Beer P.M., Van der Merwe L., Heyns C.F.
    S. Afr. Med. J. 100:741-745(2010) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech, Sequences.
    Annotation: Observational study of gene-disease association. (HuGE Navigator).
    Source: GeneRIF:64816.

    This publication is mapped to 3 other entries.

  21. 21
    "No influence of CYP3A43 rs472660G> A on steady-state serum olanzapine concentrations in white psychiatric patients."
    Soderberg M.M., Molden E., Dahl M.L.
    Pharmacogenet. Genomics 24:272-275(2014) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech, Sequences.
    Annotation: CYP3A43 rs472660 is not likely to be a major contributor towards variability in systemic OLA exposure among White patients.
    Source: GeneRIF:64816.

    This publication is mapped to 3 other entries.

  22. 22
    "Genetic variation in CYP3A43 is associated with response to antipsychotic medication."
    Brandl E.J., Chowdhury N.I., Tiwari A.K., Lett T.A., Meltzer H.Y., Kennedy J.L., Muller D.J.
    J Neural Transm (Vienna) 122:29-34(2015) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Annotation: This review support the notion that the SNP CYP3A43this may play a role in antipsychotic response.
    Source: GeneRIF:64816.

    This publication is mapped to 3 other entries.

  23. 23
    "Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer."
    Hunter S.M., Rowley S.M., Clouston D., Li J., Lupat R., Krishnananthan N., Risbridger G., Taylor R., Bolton D., Campbell I.G., Thorne H.
    Urol. Oncol. 34:120.e9-16(2016) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech, Sequences.
    Annotation: Mutations in CYP3A43 gene is associated with prostate cancer.
    Source: GeneRIF:64816.

    This publication is mapped to 10 other entries.

  24. 24
    "Ancestry-Adjusted Vitamin D Metabolite Concentrations in Association With Cytochrome P450 3A Polymorphisms."
    Wilson R.T., Masters L.D., Barnholtz-Sloan J.S., Salzberg A.C., Hartman T.J.
    Am. J. Epidemiol. 187:754-766(2018) [PubMed] [Europe PMC] [Abstract]
    Category: Function, Interaction.
    Annotation: We investigated the association between genetic polymorphisms in VDR cytochrome P450 (CYP2R1 CYP24A1 and the CYP3A family) with plasma concentrations of vitamin D metabolites (25-hydroxyvitamin D3 (25(OH)D3) and proportion 24 25-dihydroxyvitamin D3 (24 25(OH)2D3)) among individuals of sub-Saharan African and European ancestry. Only CYP3A43 and VDR polymorphisms were associated with proportion 24 25(OH)2D.
    Source: GeneRIF:64816.

    This publication is mapped to 18 other entries.

  25. 25
    "The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4."
    Gallagher E.P., Kunze K.L., Stapleton P.L., Eaton D.L.
    Toxicol. Appl. Pharmacol. 141:595-606(1996) [PubMed] [Europe PMC] [Abstract]
    Category: Function.
    Annotation: Pathway.
    Source: Reactome:R-HSA-2980797.

    This publication is mapped to 5 other entries.

1 to 25 of 26  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again